|
The Summit, held annually at Harvard Medical School, focuses on strategies and best practices for demonstrating and improving the safety, effectiveness, value and quality of healthcare products and services through Phase IV studies, Patient Registries, Risk Management Programs and Quality Initiatives. On the agenda this year are several real-world case studies that address safety and risk management, multi-stakeholder collaboration, and maximizing communications with patient registries. These sessions include:
- Using a Registry for REMS and PASS Requirements presented by Dr. Eleanor Segal, MD, Vice President and Head Global Drug Safety, Actelion Pharmaceuticals
- Using a Registry to Evaluate Clinical Outcomes and Monitor Safety presented by Ms. Anne Marie Conway, Vice President, Development Operations, Shire
- Using a Registry for Multi-Stakeholder Needs presented by Dr. Bruce Marshall, MD, Vice President of Clinical Affairs, Cystic Fibrosis Foundation
- Maximizing Communications presented by Dr. David Cooper, MD, Director, Medical Affairs, Novo Nordisk
To learn more or to view the full agenda with confirmed speakers, please visit the Summit website at www.postapproval.org.
Register Today!
Register online at www.postapproval.org. Registration is $1,695 and each additional registrant is $1,295. Your registration includes breakfast and lunch on both days and admittance to the opening night reception at the Isabella Stewart Gardner Museum.
We look forward to seeing you in May!
The Committee for the Post-Approval Summit
201 Broadway, Cambridge, MA 02139
Tel: (617) 621-6426
Fax: (617) 621-1620
mailto:knarolewski@postapproval.org
|
